The Psychedelic Innovation Fund:

Fueling the Future of Mental Health and Neuroscience

At PSI, we believe that lasting mental health solutions should be accessible to everyone, not just a select few.

The Psychedelic Innovation Fund (PIF) supports us in this mission, serving as the philanthropic engine that powers PSI’s commitment to scientific advancement, education, equitable access, and the compassionate future of psychedelic medicine.

The psychedelic landscape is at a pivotal moment, with a rapidly expanding wave of clinical research across a wide range of mental health conditions such as depression, anxiety, PTSD, substance abuse, end-of-life distress and grief. However, the journey from promising research to widely available, insurance-covered treatments is long and requires significant support.

Donate to the Psychedelic Innovation Fund.

The Mission

Accelerating Research & Education, Expanding Access

The Psychedelic Innovation Fund directly supports PSI's core mission to:

Advance Psychedelic Science

We fund cutting-edge clinical trials and research exploring how psychedelics, as "neuroplastogens," can help optimize behavior, brain health, and quality of life. This includes investigating medicines like psilocybin, LSD, 5-MeO-DMT, MDMA, and ibogaine to help achieve FDA approval and eventual integration into mainstream healthcare.

Expand Equitable Access

We support eliminating financial barriers and ensuring that psychedelic-assisted therapies are available to a diverse and underserved populations, including BIPOC and LGBTQIA+ communities who are often overlooked in clinical research.

Support Education and Training

We aim to help train the next generation of psychedelic therapists and clinician scientists.

Innovate in Creating Psychedelic-Based Care Models

We are designing the mental health clinics of the future: affordable, sustainable, and scalable.

Your Impact:

More Than a Donation, It's a Partnership

When you contribute to the Psychedelic Innovation Fund, you become a partner in defining the next decade of psychedelic medicine. You are directly enabling research that is crucial for FDA approval and broader accessibility. This isn't about "miracle cures" or unproven claims; it's about rigorous science, structured care, and tangible progress.

Your support helps PSI continue its work as one of the few programs actively involved in developing multiple psychedelic treatments, positioning us to be among the first providers to offer these therapies upon FDA approval.

We invite you to join us in advancing this vital field, contributing to a future where effective, safe, and accessible psychedelic-assisted therapies are available to all who need them.

Ready to contribute to the future of mental health?

Donate to the Psychedelic Innovation Fund.